THERATECHNOLOGIES INC.

 THERATECHNOLOGIES INC. contact information is shown below
Owner:THERATECHNOLOGIES INC.
Owner Address:1100-2015 Rue Peel Montreal, Quebec H3A1T8 Canada
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned byTHERATECHNOLOGIES INC.

Brand:

EGRIFTA ASSIST

Description:

Providing medical assistance and medical information in the field of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain injury, visceral adipose tissue, ectopic fat and liver fat;ASSIST;

Category: PROVIDING MEDICAL ASSISTANCE MEDICAL
Brand:

EGRIFTA HC

Description:

Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain injury;

Category: PHARMACEUTICAL PREPARATIONS TREATMENT
Brand:

EGRIFTA MDV

Description:

Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain injury, nonalcoholic steathohepatitis and nonalcoholic fatty liver disease;

Category: PHARMACEUTICAL PREPARATIONS TREATMENT
Brand:

EGRIFTA SV

Description:

Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain injury;

Category: PHARMACEUTICAL PREPARATIONS TREATMENT
Brand:

EGRIFTA WR

Description:

Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain injury, nonalcoholic steathohepatitis and nonalcoholic fatty liver disease;

Category: PHARMACEUTICAL PREPARATIONS TREATMENT
Brand:

GALEMO SUPPORT

Description:

Providing medical assistance and medical information in the field of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain injury, visceral adipose tissue, ectopic fat, liver fat and HIV-1 infection and related health conditions;

Category: PROVIDING MEDICAL ASSISTANCE MEDICAL
Brand:

GALEMOPHARMA

Description:

The mark consists of the literal element GALEMOPHARMA in stylized font.;Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain injury, visceral adipose tissue, ectopic fat and liver fat; pharmaceutical preparations for the prevention and treatment of HIV-1 infection; pharmaceutical preparations;Color is not claimed as a feature of the mark.;Providing medical assistance and medical information in the field of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain injury, visceral adipose tissue, ectopic fat, liver fat and HIV-1 infection and related health conditions;

Category: